HMGCS2 and liver cancer: Parallelly, DKO in MycOE mice also displayed suppression of liver cancer development compared to littermate control mice (Fig. 6a, b).Trmt6/Trmt61a DKO reduced levels of m1A, Pparδ, and Hmgcs2 in MycOE or DEN induced liver tumor tissues (Fig. 6c).